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Summary 
We report the purification from a rat natural killer (RNK) large granular lymphocyte leukemia 
of a 32-kD granule protein that induces rapid DNA fragmentation and apoptosis. The protein, 
which we have called "fragmentin" was capable of causing DNA from intact YAC-1 cells to 
be cleaved into oligonucleosomal-sized fragments and producing severe chromatin condensation 
within 1 h.  Amino acid sequence of tryptic peptides  indicated  that  fragmentin was highly 
homologous to the NK and T cell granule serine proteases RNK protease 1 and mouse cytotoxic 
T  cell protease  I  (CCPI)/granzyme B.  Preincubation with the serine esterase inhibitor 3,4- 
dichloroisocoumarin blocked fragmentin-induced DNA damage, but had no effect on cytolysin. 
Fragmentin activity against four lymphoma target cells was completely dependent on the presence 
of cytolysin. Fragmentin produced rapid membrane damage as well as DNA fragmentation at 
nonlytic cytolysin doses, suggesting that ffagmentin activity was not limited to its effects on 
the nucleus. Fragmentin and cytolysin activity were completely inhibited by EGTA, indicating 
the process was Ca  2+ dependent. A role for cytolysin in endocytosis of ffagmentin was suggested 
by the observation that treatment of YAC-1 with cytochalasin  B or sodium azide and 2-deoxyglucose 
blocked DNA fragmentation but not cytolysin activity. A 30-kD Not-CBZ-t-lysine thiobenzyl 
esterase, which copurified with ffagmentin, was inactive on its own but was able to synergistically 
amplify the DNA damage induced by fragmentin in the presence of cytolysin. Fragmentin activity 
was not dependent on protein synthesis, as cycloheximide treatment of YAC-1 cells did not prevent 
DNA damage.  We postulate that fragmentin is the molecular mediator of NK cell-mediated 
DNA fragmentation and apoptosis. 
p revious studies have shown that during CTL and NK 
cell-mediated killing, the DNA of target cells undergoes 
rapid breakdown into oligonucleosomal fragments and cells 
die with morphological changes typical of apoptosis (1-3). 
No single molecule produced by these cells can account for 
this form of cell death. Granule exocytosis is a mechanism 
that has been proposed for the delivery of the lethal hit by 
NK cells and activated CTL (4, 5). Among the various granule 
components that have been identified and molecularly cloned 
are the homologous pore-forming proteins perforin of CTL 
(6) and cytolysin of NK cells (7). Perforin and cytolysin form 
transmembrane ionic pores that produce membrane damage 
(6-8) but do not cause DNA fragmentation (9). The exis- 
tence of some other granule components that might play a 
role in target cell DNA damage has been suggested.  How- 
ever, investigations of the DNA-fragmenting ability of iso- 
lated granules  from CTL lines  and NK cells have given 
conflicting results (10-14). We report here the purification 
from the granules of a rat NK (RNK) 1 LGL leukemia of a 
32-kD protein that induces very rapid DNA fragmentation 
with nuclear collapse and apoptosis in tumor target cells. We 
have named the protein "fragmentin" 
Materials and Methods 
Cells.  The RNK-16 tumor cell  line, used  as a source  of granules, 
has been described previously (15). It was serially passaged in- 
traperitoneaUy  in pristine-primed  Fischer  (F344) rats. The murine 
T cell lymphoma  target cells, YAC-1, SL2, EL4, and L5178Y, were 
a  Abbreviations used in this paper'. BLT, Na-CBZ-t-lysine thiobenzyl  ester; 
CCPI, mouse cytotoxic protease I; DCI, 3,4-dichloroisocoumarin; DTNB, 
5,5-dithiobis-(2-nitrobenzoic  acid);  FPLC,  fast  protein  liquid  chroma- 
tography; HF, Hanukah Factor; mlUdR, [12sI]iododeoxyuridine; RNK, 
rat  NK; RNKP-1, RNK protease 1. 
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streptomycin, and 2 mM t-glutamine. 
Isolation of Granules.  The method for isolation and solubiliza- 
tion of granules of RNK cells has been described in detail (7, 16). 
In brief, RNK cells were washed out from the peritoneum using 
cold HBSS with heparin, pelleted by centrifugation, and resuspended 
at  10  s  cells/ml  in  disruption  buffer  (0.25  M  sucrose,  10  mM 
Hepes, 4 mM EGTA, and 160 U/ml heparin, pH 7.4).  They were 
equilibrated at 0~  and at 450 psi in a nitrogen cavitation bomb 
for 20 min, then lysed by decompression. The resulting homoge- 
nate was made up to 8.8 mM MgC12 and incubated at room tem- 
perature for 25 rain with 1,000 U/ml DNase I (Sigma Chemical 
Co., St. Louis, MO). Nuclei were removed by successive filtration 
through  5-  and  3-#m  nucleopore  filters  (Nuchopore  Corp., 
Pleasanton,  CA). The resulting homogenate was cooled at 4~ 
5-6-ml aliquots were layered  on 19 ml of 48%  (wt/vol) Percoll 
in disruption buffer without heparin and centrifuged at 20,000 rpm 
at 4~  for 10 rain with 0 deceleration using a 70-Ti rotor in a cen- 
trifuge (LS-70M; Beckman Instruments, Inc., Fullerton, CA). The 
bottom-most 5 ml from the resulting gradients was harvested.  This 
granule-containing fraction was centrifuged at 34,000 rpm for 16 h 
at 40C using the same rotor, and the granules, a loose white layer 
over a hard Percoll  pellet, were collected by Pasteur pipette and 
stored at -80~  The granules were solubilized in 2 M NaC1 with 
three freeze/thaw cycles. This material was centrifuged at 34,000 
rpm for 1 h  in a 70-Ti rotor (Beckman Instruments,  Inc.). The 
supernatant  was harvested and filtered through  a  sterile  Millex 
GV4 0.22-/~m  filter (Millipore  Corp.,  Bedford,  MA)  to remove 
membrane fragments. 
Purification of Granule Proteins.  The filtered solubilized granule 
preparation (7.5  x  109 RNK cell equivalents  in a 4.5-ml volume) 
were loaded on a 1-ml phenyl superose column (HR 5/5;  Phar- 
macia LKB Biotechnology, Uppsala, Sweden) connected to a fast 
protein liquid chromatography (FPLC) system. All buffers and frac- 
tions were kept on ice. Fractions were eluted with a linear gradient 
of 2 to 0 M NaC1 in 20 mM Tris-HC1 (pH 7.2), 0.1 mM EGTA, 
and 0.02%  NaN3 buffer (TEB) as follows.  Sample was loaded in 
4.5  ml for 9 min, then the column was washed for 24 rain. A 2 
to 0 M  NaC1  linear gradient in TEB was then run for 20 min. 
The elution rate was 0.5 ml/min,  1-ml fractions were collected, 
and  the eluate was monitored by measurement of OD2so.  The 
column was run twice (1.5  x  101~  RNK cell equivalents total), 
and identical fractions were pooled. DNA-fragmenting and cytolysin 
activities were screened in  [mI]iododeoxyuridine (nsIUdR) and 
51Cr release assays using double-labeled YAC-1 cells as described 
below. All  *2SlUdR assays  contained  a  constant  amount  of 
cytolysin, which was necessary to detect activity. 
DNA-Fragmenting Protein.  Fractions  containing activity, which 
were eluted with  the  first protein  peak of the  phenyl  superose 
column, were pooled and concentrated using a Centriprep 10 con- 
centrator (Amicon, Beverly, MA) to a final volume of 2.4 ml. This 
material was diluted to 36 ml in TEB to give a final  [NaC1]  of 
"~0.145 M and aFplied on a Mono Q column (HR 5/5; Pharmacia 
LKB Biotechnology).  The sample was loaded for 36 min and washed 
for 6 min in TEB. Fractions were eluted from the Mono Q column 
with a linear gradient of 0.2 to 0.6 M NaC1 in TEB for 20 min, 
then a steeper gradient of 0.6  to 2 M  NaC1 in TEB for 6 rain. 
The flow rate was 1 ml/min, and 1-ml fractions were collected and 
screened  with  the  125IUdR release  assay. Active fractions were 
pooled, and concentrated with a Centricon 10 microconcentrator 
(Amicon) to a final volume of 1 ml and then diluted to 5 ml in 
TEB to give a final NaC1 of '~0.1 M for subsequent heparin chro- 
matography. We used an HR 5/5 column (Pharmacia LKB Bio- 
technology) that was packed with I ml of heparin-agarose gel (Pierce 
Chemical Co., Rockford, IL) and connected to the FPLC system. 
Samples were loaded for 25 min, and the column was washed for 
25 min with TEB. Fractions were eluted with a linear gradient 
of 0 to I  M  NaC1 in TEB for 100 rain.  The flow rate was 0.2 
ml/min, and I ml fractions were collected and screened for activity. 
Active fractions from the heparin-agarose chromatography were 
pooled and concentrated; the buffer was changed to 10 mM bis- 
Tris, pH 6.0, containing 50 mM NaC1;  then  12 ml was applied 
to Mono S beads (HR 5/5) for 12 min, and then the column was 
washed with 10 mM bis-Tris for 8 min. Fractions were eluted with 
a linear gradient of 10 mM bis-Tris, pH 6.0, containing 0-1 M NaC1 
with a flow rate of 1 ml/min for 20 rain. DNA-fragmenting ac- 
tivity was detected in the first protein peak at 0.75 M NaC1. The 
complete purification protocol was run continuously over a 2-3-d 
period,  storing samples at 4~  between chromatographic steps. 
Cytolysin.  A simple and rapid method for purifying cytolysin 
was developed. The cytolysin-containing fractions eluted from the 
phenyl superose column were usually stored at  -80~  Samples 
were then thawed, pooled, and concentrated with Centricon 30 
microcentrators (Amicon) to a final volume of 1.0 ml. This mate- 
rial was diluted to 10 ml with TEB to give a final [NaC1] of,,o0.1 M 
and loaded on the FPLC heparin-agarose column. Fractions were 
eluted with three gradients, 6 min of 0-0.3 M  NaC1, 40 min of 
0.3-0.5  M  NaC1, and 30 rain of 0.5-1.0 M  NaC1 in TEB. The 
flow rate was 0.5 ml/min, and 1-ml fractions were collected and 
screened with a 51Cr-release assay and No~-CBZ-t-lysine thiobenzyl 
ester (BLT) esterase  assay. The purity of each fraction from the 
peak of cytolytic activity was assessed by SDS-PAGE.  Experimen- 
tally useful amounts of pure cytolysin could be obtained from an 
initial loading on the phenyl superose column of as little as 4  x 
109 cell equivalents of solubilized granule preparation. 
Tryptic Peptide Sequencing.  Tryptic peptide cleavage fragments 
for internal sequence analysis were prepared as described  (17). Sepa- 
rated proteins were electroblotted onto nitrocellulose and detected 
on the membrane by Amido black staining. The region where the 
32-kD  protein was bound  was sliced  out,  and  the protein was 
digested on the matrix with trypsin. The resulting peptides were 
separated by reverse-phase HPLC on a C4 column (150  x  2.1 mm; 
Vydac  Separations  Group,  Hesperia,  CA)  in  a peptide analyzer 
(Waters, Inc., Rochester, MN) using a trifluoroacetic acid/acetoni- 
trile buffer system. Prominent peptides were collected manually 
and frozen immediately. Sequence  analysis was performed on a se- 
quencer (477;  Applied Biosystems, Inc., Foster City, CA) using 
standard protocols. 
"Cr and 125IUdR Release Assay.  Target ceils in the log phase 
of growth (2.5  x  10Vml) were labeled as described by Russell et 
al. (3) with some modifications. Briefly, 20-40/zCi lzSlUdR and 
in  some experiments  also  100 #Ci  sodium SICr-chromate were 
added to 2-5  x  106 target cells in 0.5 ml of supplemented RPMI, 
the cells were incubated at 37~  in a 5% COs atmosphere for 90 
min, washed once in HBSS, incubated an additional 45 min, then 
washed twice and resuspended at 1-2  x  105 cells/ml in HBSS con- 
taining 2 mM CaC12 10 mM Hepes, 4 mg/ml BSA, pH 7.4. We 
only used double-labeled cells for which 12SlUdR cpm and 51Cr 
cpm did not differ by more than a factor of 2. Aliquots of 104 cells 
in 100/A were added to 100/A of granule-derived material (with 
[NaC1] adjusted to 140 mM) that had been diluted in normal saline 
with  10 mM Hepes and  1 mM EGTA (at pH 7.4) in 96-well, 
V-bottomed microtiter plates kept on ice. Assays in which the effect 
of various chemicals were analyzed utilized a similar procedure ex- 
cept that 104 cells were delivered in 50 ~1 and the chemical in 50 
/A. Cytochalasin B (Sigma Chemical Co.) was dissolved in DMSO 
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tion of 20 mM and stored at 4~  Sodium azide (Sigma Chemical 
Co.) and 2-deoxyglucose (Sigma Chemical Co.) were made fresh 
in assay medium.  Target cells were incubated  6-8 h at 37~  in 
cytochalasin B, and 5 h with sodium azide or 2-deoxyglucose be- 
fore addition of granule proteins. Cycloheximide (Sigma Chemical 
Co.) was prepared in assay medium.  Target cells were incubated 
for 2 h at 37~  with cycloheximide before the cytotoxicity assay. 
The plates were then incubated at 37~  for the times indicated 
and subsequently centrifuged  at 800 g for 5 rain. In the lzsIUdR 
release experiments, 80 #1 of target cells and 80 #1 of test protein 
were incubated,  then 40 #1 of 1% Triton X-100, 5 mM EGTA, 
and 50 mM Tris-HC1 (pH 7.2) was added to reaction wells, the 
well contents were mixed, and the plates were centrifuged. In both 
sets of experiments, 100 #1 of supematant was harvested from each 
well, and the corresponding SlCr cpm and 12SlUdR cpm were de- 
termined in a Wallac LKB 1282 Compugamma universal gamma 
counter (Pharmacia LKB Biotechnology),  correcting  for overlap- 
ping energy spectra. The specific isotope release was determined 
as described previously (16). 
Calculation of Lytic Units.  For PSIUdR and SlCr rehase assays, 
we defined one lytic unit as the amount of protein that gave 50% 
specific 12SlUdR or S~Cr release from 104 YAC-1 cells. For calcu- 
lations of specific activity in lytic units per milligram, protein con- 
centrations were determined using a bicinchoninic acid protein assay 
kit (Micro BCA; Pierce Chemical Co., Rockford,  IL) adapted to 
96-well plates. Readings were made in an ELISA reader (Titertek, 
Multiskan MCC/340 MK II; Flow Laboratories Inc., Mississauga, 
Ontario) with a 540-nm filter. For the heinolysis assay, we defined 
1 hemolytic unit of cytolysin as the amount of material (#1) that 
gave 50% hemoglobin release. Hemolytic units were used as a mea- 
sure of activity when cytolysin protein concentration  was below 
detection  limits. 
BLT Esterase Microassay.  We determined the serine esterase ac- 
tivity of individual fractions from a Percoll gradient of RNK cell 
homogenate  using a modification of the colorimetric BLT thioes- 
terase assay of Green and Shaw (18). 
The stock reagents were 10 mM BLT (Sigma Chemical Co.) 
in H20, and 10 mM 5,5-dithiobis-(2-nitrobenzoic  acid) (DTNB; 
Sigma Chemical Co.) in dimethyl formamide. These were further 
diluted in HBSS-Hepes (10 mM) to 1 mM BLT and to 0.5 mM 
DTNK respectively.  Each well of a 96-well flat- or round-bottomed 
microtiter  plate received dilute DTNB solution.  To the reaction 
wells, we added 50 #1 of dilute  BLT solution,  whereas to their 
"blank" counterparts  we added 50 #1 of HBSS-Hepes. We added 
100 #1 of appropriately diluted (in HBSS-Hepes) Percoll gradient 
fractions to both sets of wells, mixed well contents on a plate shaker 
for 10 min, and incubated a further 30 min at room temperature. 
The BLT esterase activity in each well was determined  by mea- 
suring the absorbance at 414 on a Titertek Multiskan plate reader. 
It is assumed that OD is linear with enzyme dose. 
SDS-Polyacrylamide Gel Electrophoresis.  Proteins  were run on 
6-cm-long 12% gel slabs according to Laemmli (19). An additional 
2 cm of 4% gel was added over the running gel to resolve high 
Mt bands. Gels were developed using a commercial silver stain kit 
(Bio-Rad Laboratories, Richmond,  CA). 
Results 
Purification of a 32-kD Protein with DNA Fragmenting Ac- 
tivity.  To identify and purify the putative granule  DNA- 
fragmenting molecule, we isolated cytoplasmic granules from 
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RNK cells as described previously (7, 16), and two aliquots 
of 0.75  x  101~  cell  equivalents  were  solubilized  in  2  M 
NaC1 and subjected to FPLC chromatography (see Materials 
and Methods). After an initial step of phenyl superose chro- 
matography,  we found two protein peaks (Fig.  1 A).  The 
second peak had cytolysin activity but caused no DNA damage 
in  double-labeled  (SlCr  and  *2SlUdR)  YAC-1  target  cells. 
The  first protein  peak induced  12SlUdR  release  only after 
combining it with the cytolysin containing  fractions  (Fig. 
I a). The possibility that the DNA fragmentation required 
the presence of cytolysin from the second peak was confirmed 
utilizing purified cytolysin prepared by sequential Ultragel 
AcA54 and heparin-agarose chromatography as described ear- 
lier (16) or phenyl superose and heparin-agarose as described 
in Materials and Methods. In all subsequent chromatographic 
steps, we screened for DNA-fragmenting activity in the pres- 
ence of cytolysin. The first protein peak from the phenyl su- 
perose chromatography was pooled,  concentrated,  and de- 
salted, and then applied to a Mono-Q column. The fractions 
containing  the DNA-fragmenting  activity (Fig.  1 B) were 
pooled and concentrated,  then applied to a heparin-agarose 
affinity column. Following heparin chromatography, a single 
peak of protein containing DNA-damaging activity was ob- 
served (Fig.  1 C), which ran as two major bands of 30- and 
32-kD and a minor 31-kD band on SDS-PAGE after reduc- 
tion (Fig.  1 E).  The active fractions of the heparin-agarose 
chromatography  were pooled, concentrated,  and subjected 
to Mono S chromatography. Two protein peaks were identified 
(Fig.  1 D);  the first contained DNA-ffagmenting  activity, 
and the second was a BLT esterase.  The first peak contained 
the major 32-kD protein,  which ran at 31 kD under non- 
reducing conditions (Fig. 1 E). The second protein peak that 
had BLT esterase activity was 30 kD under reducing and 28 
kD under nonreducing conditions (Fig. 1 E). The minor 31- 
kD  protein  eluted between the  two peaks.  Recovery and 
purification for each step are presented in Table  1. The 32- 
kD protein was named "fragmentin"  after its ability to in- 
duce DNA fragmentation. 
Cytolysin was purified by a new two-step method using 
phenyl  superose and heparin-agarose  chromatography  (see 
Materials and Methods). The initial phenyl superose step sepa- 
rated the cytolysin from most granules proteins including frag- 
mentin (Fig.  1 A). The heparin-agarose step removed a con- 
taminating  BLT esterase (Fig.  2) and yielded a single band 
of 65-kD on SDS-PAGE under reducing conditions (Fig.  2) 
with  a recovery of 12-15%  and purification  of >300-fold 
(Table 1). 
Fragmentin  Is Homologous  to RNKP-1  and CCPI.  Four 
tryptic peptides of fragmentin were prepared and sequenced 
(17).  The amino acid sequence is given in Fig. 3 and com- 
pared with the deduced amino acid sequences of three granule 
proteases: the RNK protease 1 (RNKP-1), which was cloned 
from the same RNK-16 tumor used to purify fragmentin (20), 
the routine T cell granule proteases CCPI/Granzyme B (21), 
and Hanukah  Factor (HF)/Granzyme  A  (22).  Fragmentin 
was highly homologous to RNKP-1, differing in only two 
of 41 identifiable amino acids.  CCPI/Granzyme B was also 
closely related as it differed in seven amino  acids,  whereas Figure 1.  Purification of an RNK granule protein that induces DNA fragmenta- 
tion. (,'t) Phenyl Superose chromatography.  Granules (7.5  x  109 RNK cell equiva- 
lents) were solubilized in 2 M NaC1, centrifuged,  and filtered to remove debris, and 
then applied on a FPLC phenyl-Superose column and eluted with a reducing linear 
gradient of from 2 M to 0 NaC1. Fractions were adjusted to 0.15 M NaC1, then assayed 
against slCr- and t2SlUdR-double-labeled  YAC-1 cells. The first protein peak exhibited 
DNA-fragmenting activity, but this was seen only in the presence of cytolysin. Frac- 
tions were, therefore, assayed for DNA damage with an equal amount of cytolysin 
added to each sample. (B) Mono Q chromatography.  Active fractions from two runs 
of phenyl Superose chromatography  were concentrated and desalted, then applied to 
Mono Q beads. Fractions were eluted with a gradient of from 0 to 2 M NaC1. DNA 
fragmenting activity was detected  in eluate of  0.3-0.5 M NaC1 in the presence  of  cytolysin. 
(C') Heparin-agarose chromatography. Active fractions from the Mono Q column were 
pooled, concentrated, and applied to a heparin-agarose column. Fractions were eluted 
with a gradient of 0 to 1 M NaCI. DNA-fragmenting activity was eluted at 0.5-0.6 
M NaC1 in a single protein peak. (/9) Mono S chromatography. Active fractions from 
the heparin-agarose chromatography  were pooled, concentrated,  and buffer changed 
to 50 mM NaC1, and then applied to Mono S beads. Fractions were eluted with a 
linear gradient of 0 to 1 M NaCI. DNA-fragmenting activity was detected in the first 
protein peak at 0.75 M NaCI. The second peak was a BLT esterase. (E) SDS-PAGE 
of heparin agarose and Mono S protein peaks. 15/~1 of sample containing 800 ng of 
protein was loaded on a 12% gel run according to Laemmli (19) under reducing condi- 
tions (100 mM dithiothreitol  at 95~  for 3 min). Lane 1, molecular mass standards; 
lane 2, heparin-agarose  fraction 22; lane 3, Mono S fraction 65 containing DNA-damaging 
activity; and lane 4, Mono S fraction 71. lanes 5-7 correspond  to the same protein 
peaks run under nonreducing  conditions  using 1,600 ng of protein per lane. Molecular 
mass standards for gels run under nonreducing  conditions are given on the right. Gels 
were  silver stained  according to  manufacturers  instructioffs  (BioRad,  Mississauga, 
Ontario). 
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Protein  Total activity*  Activity yield  Specific activity  Purification 
mg  U  ~  U/mg  fo~ 
Fragmentin 
Granules  18  3.2  x  104  100  1.78  x  103  1.0 
Phenyl Superose  16.5  2.7  ￿  104  84  1.64  x  103  0.92 
Mono  Q  0.546  1.3  x  104  41  2.38  x  104  13.4 
Heparin Agarose  0.171  5.8  x  103  18  3.39  x  104  19.0 
Mono  S  0.06  3.5  x  103  11  5.83  x  104  32.8 
Cytolysin 
Granules  54  1.5  x  10  s  100  2.8  x  10  z  1.0 
Phenyl Superose  1.28  1.2  x  10  s  80  9.4  ￿  104  33.6 
Heparin Agarose  0.022  1.9  ￿  104  12.7  8.6  x  10  s  307.0 
* A unit of fragmentin activity was defined as the amount required to produce 50% release of 12SlUdR from  104 YAC-1 cells. A unit of cytolysin 
activity  was the amount producing 50% release of SlCr from 104 YAC-1 cells. 
19 amino acids did not match the corresponding HF/Gran- 
zyme A  sequence. 
Fragmentin Induces  DNA Fragmentation and Apoptosis.  Duke 
et al. (1, 2) found that NK cells could cleave YAC-1 target 
cell DNA into oligonucleosomal-sized fragments that gave 
a ladder-like  pattern on gel electrophoresis.  We incubated 
106 unlabeled YAC-1 cells with the purified protein and/or 
cytolysin for 4 h at 37~  then extracted the DNA, and sub- 
jected it to agarose gel electrophoresis and ethidium bromide 
staining. Fig. 4 shows that the protein and cytolysin together 
caused  a DNA ladder,  whereas each alone was inactive. 
Time-lapse morphological examination of YAC-1 over a 
2-h period following incubation with the protein and cytolysin 
revealed extensive blebbing of the cell surface and convolu- 
tion of the nuclear membrane, which are typical of CTI: 
induced damage and apoptosis (23-25).  Cell death was as- 
sociated with nuclear collapse and severe chromatin conden- 
sation within 1 h, which was visualized as apoptotic bodies 
(24,  25)  by transmission electron microscopy (Fig.  5 D). 
Cytolysin alone produced membrane damage without chro- 
matin condensation (Fig. 5 C), whereas the fragmentin by 
itself was without effect (Fig.  5 B). 
Figure 2.  Cytolysin purification.  (A) Heparin-agarose chromatography.  Cytolysin-containing  fractions from the phenyl-Superose column (Fig.  1 
a) were pooled, concentrated,  applied to the heparin agarose column, and eluted with three gradients: 0-0.3, 0.3-0.5, and 0.5'1.0 M NaC1. The first 
protein peak was cytolysin, and two subsequent peaks had BLT esterase activity. (B) SDS-PAGE of cytolysin. Samples (8/~1) of cytolysin eluted from 
heparin-agarose column  were loaded on a 12% gel run according to Laemmli (19) under nonreducing  conditions. Lanes 5-9 were heparin-agarose fraction 
25-29 containing  cytolysin activity. The protein concentration  of the peak at fraction 27 was 25/~g/ml, and 0.2/~g was loaded in lane 7 of the SDS-PAGE. 
Molecular mass standards are given on the left.  Gels were silver stained. 
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Figure 3. 
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Val -Asp -  Pro -Cly -Asp-Val  -Xxx -Tyr -Val -Ala-Gly-Xxx-gly 
*  -Lys-  *  -  *  -  *  -  *  -Cys-  *  -  *  -  *  -  *  -Trp-  * 
*  -Lys-  *  -  *  -  *  -  *  -Cys-  *  -  *  -  *  -  *  -Trp-  * 
*  -Lys-  *  -  *  -Thr-Arg-Cys-Arg-  *  -  *  -  *  -Trp-  * 
Amino acid sequence of tryptic peptides of fragmentin. 
Cytolysi, Dependence of Fragmentin-Induced DNA Damage. 
In the presence of a constant amount of cytolysin, fragmentin 
produced a dose-dependent increase in DNA damage as mea- 
sured by 12SlUdR release and membrane damage as measured 
by 5*Cr release,  but was inactive when presented  to target 
cells on its own (Fig.  6 A). Fragmentin  could induce DNA 
damage at a dose of cytolysin that  produced no detectable 
membrane damage (Fig.  6 A). Over the dose range of frag- 
mentin,  we first observed an increase in membrane damage 
at lower doses and this was followed by 12SlUdR release  at 
higher fragmentin concentrations.  Fig. 6 B shows that frag- 
mentin activity was also dependent on cytolysin dose, with 
both DNA and membrane damage increasing with cytolysin 
dose. However, membrane damage in the presence of frag- 
mentin was always higher than that induced by cytolysin alone. 
DNA and membrane damage were inhibited by EGTA, indi- 
cating that  the process was Ca2+-dependent  (Fig.  6 A).  In 
a kinetic  analysis,  DNA and membrane  damage were seen 
as  early  as  15  rain  after  treatment  with  fragmentin  and 
cytolysin, and were maximal by 60 min (Fig.  6 C).  Mem- 
brane damage preceded the DNA damage induced by frag- 
mentin.  When examining fragmentin activity against other 
lymphoma targets, activity was detected using EL4, L5178Y, 
and SL2 tumor cells. DNA damage was found to be depen- 
dent  on the dose of cytolysin in  each tumor  although  the 
range  of sensitivity varied by 10-fold (Fig.  7). 
Although  fragmentin  has  an  absolute  requirement  for 
Figure 4.  DNA fragmentation  in YAC-1 
cells incubated with  fragmentin and 
cytolysin. Unlabeled YAC-1 cells (106) 
were incubated with 8 #g fragmentin 
and/or 0.4 #g cytolysin  in 1.0 ml HBSS, 
10 mM Hepes, and 0.2% BSA for 4 h 
at 37~  The cells were then incubated 
in sodium-N-lauroyl sarcosine and pro- 
teinase K at 50~  for 1 h. KNase  A was 
added, and the sample  was incubated  for 
a further I h, then lo~d~ on a 1% agarose 
gel and electrophoresed. The gel was 
stained with ethidium bromide  and visual- 
ized under UV light. 
cytolysin, even at  sublytic doses, the mechanism by which 
it promotes fragmentin activity is not immediately apparent. 
One possibility is that cytolysin insertion into the plasma mem- 
brane might  stimulate  endocytosis and  thus facilitate frag- 
mentin movement from the extracellular space to the cyto- 
plasm.  To test  this  hypothesis,  we examined  the effects of 
cytochalasin B, an inhibitor of micro  filament assembly, and 
of sodium azide and 2-deoxyglucose which, respectively, in- 
hibit  mitochondrial  respiration  and  glycolysis. Both  cyto- 
chalasin  B and metabolic inhibitors block receptor-mediated 
endocytosis (26).  We found that  cytochalasin B completely 
blocked DNA and membrane damage by fragmentin without 
affecting cytolysin activity (Fig. 8 A). Furthermore,  sodium 
azide and 2-deoxyglucose when combined also effectively in- 
hibited fragmentin  activity  (Fig.  8 B). 
Inhibition of Fragmentin by Protease Inhibitors.  The struc- 
tural homology of fragmentin  to granzymes  RNKP-1 and 
CCPI suggested that its ability to induce DNA fragmenta- 
tion was related  to its proteolytic activity.  To test this  hy- 
pothesis,  we preincubated 40 ng of fragmentin  for 30 min 
at  37~  with  increasing  doses of 3,4-dichloroisocoumarin 
(DCI), a general serine protease inhibitor  (27) that is a po- 
tent inhibitor of lymphocyte proteases (28), and PMSF, a serine 
Figure 5.  Electron  micrograph of YAC-1 lymphoma following incubation with fragmentin and cytolysin. YAC-1 cells were incubated for 1 h with 
control medium (A) and with fragmentin only (B), cytolysin  only (C), and fragmentin and cytolysin  (D). The highly condensed chromatin seen in 
D (arrows)  are apoptotic bodies. 
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protease inhibitor that can partially block RNK-16 granule 
cytotoxicity (11). DCI completely blocked fragmentin activity 
with an IDs0 of 15/xM without affecting cytolysin (Table 
2). The latter control was important, as loss of activity could 
have been due to cytolysin inactivation.  PMSF, with an ID50 
of 360 #M, on the other hand, was much less effective than 
DCI (Table 2). 
Fragmentin Activity Is Not Dependent on Protein Synthesis.  To 
determine whether fragmentin-induced  DNA fragmentation 
was dependent on new protein synthesis,  we examined its 
re 
re 
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Figure  7.  Target cell susceptibility  to fragmentin-induced DNA damage 
is cytolysin dependent. A variable degree of DNA damage was produced 
by 1/Lg fragmentin at increasing cytolysin doses in these cell lines. An 
"~10-fold difference was detected between the SL2 and EL4 lymphomas. 
activity in cells pretreated with 50/~g/ml cycloheximide for 
2 h at 37~  Fragmentin activity over a wide dose range was 
unaffected by cycloheximide (Fig. 9), and cydoheximide from 
I to 50/xg/ml did not alter fragmentin-induced  DNA damage 
(not shown). 
BLT Esterase Amplifies Fragmentin Activity.  The relatively 
low fragmentin purification factor of 33-fold  (see Table 1) 
was unexpected, and may have been the result of the lability 
of the molecule and loss of activity during purification. Al- 
ternatively, another molecule could have been separated during 
the  purification  that  could  amplify  fragmentin  activity. 
Copurification of fragmentin with a second protein with BLT 
esterase activity (see Fig.  1 D) suggested that this protein 
may have been the putative amplifying molecule. At a pro- 
tein concentration up to 1/zg/ml, the BLT esterase was inac- 
tive. However,  it was capable of enhancing fragmentin ac- 
tivity in a synergistic  manner (Fig.  10). The amplification 
was ,,o  five-fold at the EDs0 (Fig. 10). In this experiment, we 
also examined the requirement for Triton X-100 solubiliza- 
tion of the target cell to release soluble 12SlUdR after incu- 
bation with fragmentin, cytolysin, and the BLT esterase. Al- 
though Triton X-100 enhanced the release of DNA, 20-40% 
of total 12SlUdR was released in the absence of the deter- 
gent (Fig.  10, A  and B). 
Discussion 
Although the phenomenon of DNA fragmentation induced 
by lymphocyte-mediated killing has been known for many 
years, the exact molecular mechanisms have not been deter- 
mined. Candidate molecules such as lymphotoxin (29, 30), 
TNF-ol  (31), Granzyme A  (11, 32),  and other cytotoxins 
(33-35) have been suggested as possible mediators. The results 
of the present study show that the granules of an NK cell 
tumor line contain both cytolysin and a second 32-kD pro- 
tein, fragmentin, that together can induce rapid DNA damage 
in target cells. 
We were able to devise purification strategies that allowed 
us to recover useful amounts of both fragmentin and cytolysin. 
A major problem of obtaining sufficient granules for large- 
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Exp.  Protease inhibitor*  Fragmentin  Cytolysin 
Percent  t~IUdK 
release 
(percent inhibition)~ 
Percent SlCr 
release 
(percent inhibition) 
/,r  ng/ml  ng/ml 
DCI 
0  250  62.5 
1  250  62.5 
4  250  62.5 
16  250  62.5 
64  250  62.5 
128  250  62.5 
128  0  0 
DCI 
0  -  62.5 
1  -  62.5 
4  -  62.5 
16  -  62.5 
64  -  62.5 
128  -  62.5 
128  -  0 
PMSF 
0  250  62.5 
16  250  62.5 
32  250  62.5 
62  250  62.5 
125  250  62.5 
250  250  62.5 
500  250  62.5 
DMSO  250  62.5 
500  0  0 
PMSF 
0  -  62.5 
16  -  62.5 
32  -  62.5 
62  -  62.5 
125  -  62.5 
250  -  62.5 
500  -  62.5 
DMSO*  -  62.5 
500  -  0 
66 
60  (10) 
52  (22) 
34  (51) 
6  (95) 
3  (100) 
3 
67 
64 (3) 
58  (13) 
61  (9) 
59 (12) 
48  (28) 
20 (70) 
65  (2) 
0 
74 
72  (2) 
73  (1) 
72 (2) 
72 (2) 
73  (1) 
74 
58 
57  (2) 
57  (2) 
57  (2) 
59 
55  (3) 
57  (2) 
57 (2) 
0 
* DCI and PMSF were prepared as stock solutions of 200 mM in DMSO. The solvent control is 0.25%  DMSO. 
* IDs0 of DCI was 15 #M and PMSF was 360 #M. 
scale purification was overcome by the selection of an RNK 
subline  that  yielded very high  intraperitoneal recovery of 
tumor,  •3-4  x  109  cells per rat.  Furthermore,  the frag- 
mentin purification protocol was designed to avoid inactiva- 
tion of the molecule by repeated freezing and thawing, and 
to take account of its complete dependence on cytolysin to 
mediate effector action against YAC-1. The use of HPI.C meth- 
odology was avoided because HPLC solvents inactivated frag- 
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mentin. The existence in T cell or NK cell granules of a mol- 
ecule capable of inducing DNA fragmentation has been quite 
controversial  (10-14). Based on our experimental observations, 
we suspect that the cytolysin dependence of fragmentin ac- 
tivity and the lability of the molecule may have thwarted 
previous purification  attempts. 
The high degree of homology of fragmentin to KNKP-1 
(20) and somewhat lower degree of homology to CCPI (21) 
indicate that the molecule is a granzyme. The sequence data 
do not allow us to conclusively determine if fragmentin and 
KNKP-1 are identical or very closely related. Zunino et al. 
(20) suggested that  dissimilar sequences in the S' substrate 
binding site at amino acids 17-29 of KNKP-1 and CCPI in- 
dicate that they are not species homologues. We do not have 
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Figure 9.  Fragmentin  activity  does  not require protein synthesis. YAC-1 
cells were incubated with cycloheximide  (A) (50 #g/ml) for 2 h before 
addition of fragmentin and cytolysin. Control, A. Similar results were 
obtained with a cycloheximide dose response of 1-50 #g/ml. 
sequence from this region and therefore cannot exclude the 
possibility that fragmentin is a species homologue of CCPI. 
Further  evidence that  fragmentin  is part of the granzyme 
family is the inhibition of DNA fragmentation by the serine 
protease inhibitor DCI.  Hudig et al.  (28) recently reported 
that RNK-16 granule lysis of YAC-1 cells measured as 5tCr 
release  was inhibited when protease activity was abolished 
by DCI.  Our data indicate that  the primary effect of DCI 
is on fragmentin-mediated DNA fragmentation and not on 
cytolysin-induced membrane  damage. 
Hayes et al. (32) found that immunoaffinity-purified Gran- 
zyme A from CTL granules was capable of inducing DNA 
damage in Triton X-100-permeabilized targets and in intact 
targets in the presence of cytolysin. Neither fragmentin nor 
the BLT esterase we have identified is Granyzme A. The mo- 
lecular mass of Granzyme A in nonreducing  gels is 60 kD 
compared with 28 kD for the BLT esterase,  and the deduced 
amino acid sequence differs significantly from the tryptic pep- 
tides of fragmentin.  Our inability to identify Granzyme A 
as a mediator of DNA damage in the screening assays may 
be due to its relatively low specific activity compared with 
fragmentin.  Alternatively, it could have been inactivated in 
our purification protocol. In comparing the effects of Gran- 
zyme A reported by Hayes et al. (32) to fragmentin, we found 
that they are comparable in their requirement  for cytolysin 
to induce DNA damage. However, Granzyme A appears to 
differ in  its  absolute requirement  for  detergent  to release 
damaged DNA from target cells at the termination  of the 
assay. Fragmentin liberated up to 40% of the labeled DNA 
in the absence of Triton X-100. This would suggest that frag- 
mentin  can  damage  the  cell  compartment  in  which  the 
damaged DNA is retained.  This most likely is the nuclear 
membrane. 
The cytolysin purification protocol described here utilized 
sequential chromatography by hydrophobic phenyl superose 
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Figure  10.  Synergistic amplifi- 
cation of fragmentin activity by a 
granule  BLT-esterase. YAC-1 target 
cells were incubated with increasing 
doses of ffagmentin and a constant 
amount  of cytolysin  (68  ng/ml) 
with or without a constant amount 
of the BLT-esterase  (640 ng/ml) that 
copurified with fragmentin (see  Fig. 
1, D and E).  12SlUdR release was 
assayed without (A) or with (B) 
Triton X-100 added immediately be- 
fore assay termination after 2 h in- 
cubation. 
and heparin-agarose a~nity columns. A  hydrophobic step 
useful for perforin purification has been reported by Ishiura 
et al. (36). Although cytolysin/perforin has no obvious regions 
of hydrophobicity, it does have an amphipathic c~-helical  re- 
gion that is a potential lipid-binding domain (37-39).  Be- 
cause cytolysin/perforin displays an overall negative surface 
charge and does not bind to lipid membranes in the absence 
of Ca  2+ , it has been suggested that Ca  2+ induces conforma- 
tional changes which may result in exposure of lipid-binding 
domains (40).  Our successful use of phenyl superose chro- 
matography supports this model and indicates  that a high 
salt environment in the absence of Ca  2+ can reversibly in- 
duce exposure of this hydrophobic domain. 
The purified cytolysin did not induce DNA damage. This 
disagrees with the findings of Hameed et al. (14) but sup- 
ports work from Duke et al.  (9). Furthermore, we found 
that whereas purified fragmentin was inactive on its own, 
DNA damage occurred in a dose-dependent manner in the 
presence of purified cytolysin. Interestingly, we observed mem- 
brane damage at fragmentin doses and times that showed no 
DNA damage. Furthermore, greater membrane damage was 
always observed in the presence of fragmentin than was pro- 
duced by cytolysin alone, and, in some instances,  cytolysin 
doses were chosen that produced no membrane damage. This 
strongly suggests that the fragmentin is either directly in- 
ducing membrane damage, or is greatly enhancing the effects 
of cytolysin. The inhibition of fragmentin, but not cytolysin- 
induced membrane damage by cytochalasin  B (see Fig.  7), 
suggests that fragmentin may not be acting solely to amplify 
cytolysin activity. Because membrane damage was observed 
at ffagmentin doses that did not produce 12SlUdR release, 
this also indicated that membrane disruption cannot simply 
be secondary to DNA damage. Overall, this argues that frag- 
mentin may have an independent effect on the cell membrane 
and that nuclear damage is in some way associated with or 
a consequence of this action. Although this might also sug- 
gest that DNA damage may not be necessary for cell death 
by fragmentin, further study will be needed to darify this issue. 
The speed of DNA damage and nuclear collapse induced 
by fragmentin is typical of the rapid target damage induced 
by CTL (41). This contrasts with the extended times required 
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for DNA fragmentation after anti-CD3 antibody, irradiation, 
and Ca ionophore treatments. The observation that apop- 
tosis by these agents is blocked by inhibitors of transcription 
or translation suggests that time is required for protein syn- 
thesis (4244). The requirement for protein synthesis in apop- 
totic CTL targets is somewhat controversial, with some reports 
indicating that none is required (2), whereas others suggest 
that it is necessary to produce DNA damage (45). Fragmentin 
activity does not require protein synthesis (see Fig. 9). It seems 
possible that a molecule having similar effects to fragmentin 
may be synthesized in cells triggered to undergo apoptosis 
by other agents. Fragmentin, on the other hand, appears to 
bypass this step and directly deliver the lethal hit. 
Fragmentin-mediated DNA  damage  was  Ca2+-depen  - 
dent, and this is consistent with the Ca2+-dependent DNA 
fragmentation mediated by NK and lymphokine-activated 
killer cells (1, 14). The Ca2+-dependency of fragmentin may 
be related to both cytolysin and fragmentin activity. Cytolysin 
insertion, polymerization in target membranes, and subse- 
quent induction of membrane damage is Ca  2  + dependent 
(6-8).  Cytolysin-mediated increases  in  intracellular Ca  2+ 
(46) may also be important for DNA fragmentation. How- 
ever, replacing cytolysin by the calcium ionophore, ionomycin, 
over a wide dose range was not able to promote fragmentin- 
induced DNA damage (Shi, L., and A. H. Greenberg, un- 
published results). Thus, increased intraceUular Ca  2+ cannot 
be the only way in which cytolysin contributed to fragmentin 
activity.  This does not exclude a role for Ca  2+  once frag- 
mentin has entered the cell. McConkey et al. (47) found that 
NK cell-mediated DNA fragmentation was dependent on 
increased target cell intraceUular Ca  2+ . Rapid increases in cy- 
toplasmic Ca  2+ are often detected after contact with affected 
cells (10, 48). It is possible that, in addition to cytolysin mem- 
brane insertion, Ca  2+ may be important in mediating intra- 
cellular signalling.  The exact role of the increased cytosolic 
calcium in this type of cell death remains to be determined. 
Munger et  al.  (11) reported that Percoll-purified  dense 
granules from cloned mouse CTL and RNK tumor cells have 
the  ability  to  release  lzsIUdR  from  intact  nuclei  of 
detergent-permeabilized target cells. They postulated that 
cytolysin-induced membrane damage might play the same role as detergent in their experiments; that is, it allows a nucleo- 
lytic factor to gain access to the target nucleus. A small mo- 
lecular weight molecule may be able to pass through some 
cytolysin-created pores and also through nuclear pores (49, 
50). Another possibility is that target cells may endocytose 
fragmentin as they attempt to repair the membrane damage 
induced by cytolysin (51). This route of entry may be similar 
to diphtheria toxin, which creates an ionic channel to trans- 
locate the toxic protein across the endosomal plasma mem- 
brane following endocytosis (52). In support of this hypoth- 
esis, we demonstrated that cytochalasin B, 2-deoxyglucose, 
and sodium azide can completely or partially block fragmentin- 
induced  DNA  and  membrane  damage  without  reducing 
cytolysin activity. 
Granule exocytosis is a mechanism that has been proposed 
for NK cell-mediated killing  (4,  5). The presence of both 
fragmentin and cytolysin in granules of the NK cell suggests 
that they are released simultaneously following NK cell acti- 
vation and degranulation.  The delivery of both molecules 
to the target cell membrane at sites of cell-cell contact thus 
would  create  the  conditions  necessary  for  fragmentin  to 
mediate target cell DNA breakdown and apoptosis. The de- 
pendence of fragmentin-induced  injury on the presence of 
cytolysin may be an effective way of restricting the range of 
activity of this toxic molecule. 
The mechanism by which the fragmentin can produce DNA 
damage is not known. Its homology to RNKP-1 and CCPI 
indicates that it is a serine protease and as such might pro- 
duce proteolytic damage to defined substrates in the cytoplasm 
or nucleus.  The restricted substrate specificity of the gran- 
zymes (53) suggests that the target proteins are very limited. 
This contrasts with the generalized DNA fragmentation and 
release it induced in target cells. We postulate, therefore, that 
the DNA damage is a secondary phenomenon resulting from 
the degradation  of the fragrnentin  substrate.  Interestingly, 
a BLT esterase that copurified with fragmentin also promoted 
DNA damage (Fig. 1 D and Fig. 10). The BLT esterase would 
likely act at a different site than fragmentin.  This raises the 
interesting possibility that they may interact in an activating 
cascade such that the fragmentin activated the BLT esterase, 
or the BLT esterase activated an inactive fragmentin precursor. 
An alternative possibility is that they may act intracellularly 
at unique  sites on a common substrate producing  a syner- 
gistic effect on substrate degradation.  The identification of 
the substrate(s) will be key to developing a mechanistic model 
for fragmentin  action. 
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